Investment, Funding & Disinvestments

Biovac will construct the new facility at its Cape Town manufacturing site, with completion expected by 2028.

The three-day international exhibition, taking place from April 22 to 24 at the Sarit Expo Centre, has attracted participants from across Africa and beyond, reflecting growing regional demand for advanced healthcare solutions.

The acquisition will see Saga integrated into Roche’s subsidiary, Foundation Medicine, which focuses on advanced genomic profiling and personalised cancer care.

The updated platform now connects customers with companies such as Twin Health, Curai Health, Wheel, Berry Street, and Aaptiv.

Exhibitors will present a wide range of medical technologies and products, including surgical equipment, diagnostic systems, and pharmaceutical solutions.

The centre houses a 128-slice CT scanner installed under the National Equipment Service Programme (NESP).

Biogen now holds worldwide rights to the investigational therapy, felzartamab, which is currently undergoing Phase 3 clinical trials for several immune-mediated diseases.

AI Diagnostics developed its Ostium digital stethoscope and AI.TB software to support frontline healthcare providers, including nurses, pharmacists, and community health workers.

The therapy, known as NRTX-1001, uses pluripotent stem cells engineered to regulate brain activity and repair damaged neural networks.

Under the agreement, Stereotaxis will pay USD20 million upfront, with up to an additional USD25 million tied to milestone-based payments.